Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -117.97% is 469% below its 5-year average of -20.73%, near the low end of its 5-year range (-117.97%–1.36%).
As of the fiscal period ended Tuesday, June 30, 2026. 79.60% below its 12-month average of -65.69%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q4 FY2026 (2026-06-30): -117.97%.
RETURN ON EQUITY (ROE)
-117.97%
RETURN ON EQUITY (ROE) AVG TTM
-65.69%
RETURN ON EQUITY (ROE) AVG 3Y
-33.56%
RETURN ON EQUITY (ROE) AVG 5Y
-20.73%
RETURN ON EQUITY (ROE) AVG 10Y
-30.09%
RETURN ON EQUITY (ROE) AVG 15Y
-35.65%
RETURN ON EQUITY (ROE) AVG 20Y
-32.74%
CURRENT VS TTM AVG
-79.60%
CURRENT VS 3Y AVG
-251.51%
CURRENT VS 5Y AVG
-469.05%
CURRENT VS 10Y AVG
-292.05%
CURRENT VS 15Y AVG
-230.96%
CURRENT VS 20Y AVG
-260.36%
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
-180.82%
vs the sector median at left
Accuray Incorporated
Market Cap
$33.10M
Return on Equity (ROE)
-117.97%
TTM Avg
-65.69%
3Y Avg
-33.56%
5Y Avg
-20.73%
Market Cap
$33.29M
Return on Equity (ROE)
N/A
TTM Avg
105.22%
3Y Avg
53.02%
5Y Avg
47.52%
Market Cap
$32.92M
Return on Equity (ROE)
-238.24%
TTM Avg
203.84%
3Y Avg
55.01%
5Y Avg
16.87%
Market Cap
$33.39M
Return on Equity (ROE)
-248.21%
TTM Avg
-991.58%
3Y Avg
-655.25%
5Y Avg
-438.62%
Market Cap
$31.86M
Return on Equity (ROE)
-14.49%
TTM Avg
-7.92%
3Y Avg
-46.98%
5Y Avg
-261.20%
Market Cap
$34.42M
Return on Equity (ROE)
-44.50%
TTM Avg
-16.33%
3Y Avg
-36.34%
5Y Avg
-33.52%
Market Cap
$34.70M
Return on Equity (ROE)
329.02%
TTM Avg
154.76%
3Y Avg
265.18%
5Y Avg
128.71%
Market Cap
$31.61M
Return on Equity (ROE)
-86.96%
TTM Avg
-27.78%
3Y Avg
5.60%
5Y Avg
57.54%
Market Cap
$31.44M
Return on Equity (ROE)
2.91%
TTM Avg
-2.27%
3Y Avg
5.52%
5Y Avg
6.87%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Accuray Incorporated (ARAY) | $33.10M | -117.97% | -65.69% | -33.56% | -20.73% |
| Scilex Holding Company (SCLX)vs › | $33.29M | N/A | 105.22% | 53.02% | 47.52% |
| Aligos Therapeutics, Inc. (ALGS)vs › | $32.92M | -238.24% | 203.84% | 55.01% | 16.87% |
| HeartBeam, Inc. (BEAT)vs › | $33.39M | -248.21% | -991.58% | -655.25% | -438.62% |
| Rockwell Medical, Inc. (RMTI)vs › | $31.86M | -14.49% | -7.92% | -46.98% | -261.20% |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.42M | -44.50% | -16.33% | -36.34% | -33.52% |
| Elutia Inc (ELUT)vs › | $34.70M | 329.02% | 154.76% | 265.18% | 128.71% |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.61M | -86.96% | -27.78% | 5.60% | 57.54% |
| Nortech Systems Incorporated (NSYS)vs › | $31.44M | 2.91% | -2.27% | 5.52% | 6.87% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.19M | -154.06% | -1.75% | 68.54% | 60.27% |
ROE
-118.0%
ROA
-11.1%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -117.97% |
| 2026-03-31 | -110.60% |
| 2025-12-31 | -66.68% |
| 2025-09-30 | -31.22% |
| 2025-06-30 | -1.96% |
| 2025-03-31 | 1.36% |
| 2024-12-31 | -9.13% |
| 2024-09-30 | -36.55% |
| 2024-06-30 | -34.48% |
| 2024-03-31 | -52.31% |
| 2023-12-31 | -30.53% |
| 2023-09-30 | -13.35% |
| 2023-06-30 | -17.29% |
| 2023-03-31 | -18.60% |
| 2022-12-31 | -22.84% |
| 2022-09-30 | -20.79% |
| 2022-06-30 | -10.05% |
| 2022-03-31 | -25.16% |
| 2021-12-31 | -24.18% |
| 2021-09-30 | -16.91% |
| 2021-06-30 | -9.17% |
| 2021-03-31 | 5.89% |
| 2020-12-31 | 9.83% |
| 2020-09-30 | 20.14% |
| 2020-06-30 | 6.01% |
| 2020-03-31 | 4.31% |
| 2019-12-31 | -2.20% |
| 2019-09-30 | -40.46% |
| 2019-06-30 | -32.94% |
| 2019-03-31 | -33.53% |
| 2018-12-31 | -51.24% |
| 2018-09-30 | -50.36% |
| 2018-06-30 | -49.14% |
| 2018-03-31 | -63.00% |
| 2017-12-31 | -49.65% |
| 2017-09-30 | -59.69% |
| 2017-06-30 | -63.57% |
| 2017-03-31 | -69.37% |
| 2016-12-31 | -55.19% |
| 2016-09-30 | -41.98% |
| 2016-06-30 | -37.07% |
| 2016-03-31 | -32.89% |
| 2015-12-31 | -39.81% |
| 2015-09-30 | -41.76% |
| 2015-06-30 | -53.06% |
| 2015-03-31 | -58.08% |
| 2014-12-31 | -60.72% |
| 2014-09-30 | -51.64% |
| 2014-06-30 | -35.97% |
| 2014-03-31 | -46.29% |
| 2013-12-31 | -74.48% |
| 2013-09-30 | -99.95% |
| 2013-06-30 | -96.62% |
| 2013-03-31 | -85.84% |
| 2012-12-31 | -58.64% |
| 2012-09-30 | -40.28% |
| 2012-06-30 | -36.83% |
| 2012-03-31 | -36.35% |
| 2011-12-31 | -28.11% |
| 2011-09-30 | -21.11% |
| 2011-06-30 | -11.61% |
| 2011-03-31 | 1.85% |
| 2010-12-31 | 3.80% |
| 2010-09-30 | 0.87% |
| 2010-06-30 | 1.67% |
| 2010-03-31 | -0.59% |
| 2007-09-29 | -3.98% |
| 2007-06-30 | -4.48% |
| 2007-03-31 | -11.64% |
